 |
 |
On Dec 4, 2015, at 8:19 AM, Kathleen Cochran wrote: > http://www.nytimes.com/2015/11/21/us/politics/administration-is-seeking-ways-to-keep-prescription-drugs-affordable.html?_r=0 > > Here's an article from the NYTimes (Nov. 21) that focuses on costs but does > not mention nilotinib or the Georgetown study. The reporter does quote the > president of Novartis. > > I wrote to the reporter. Hope to hear back from him. > > Kathleen > > P.S. Maybe the reason the video does not mention costs is that it comes > from a Canadian broadcaster! Not a big issue there. Wish we in the US could > say the same. > > On 4 December 2015 at 02:08, Nic Marais <[log in to unmask]> wrote: > >> No mention of costs...;-) >> >> Nic 63/21 >> >> On 3 December 2015 at 19:11, Rayilyn Brown <[log in to unmask]> wrote: >> >>> >>> >> http://www.ctvnews.ca/health/cancer-drug-shows-promise-for-reversing-symptoms-of-parkinson-s-disease-1.2615703 >>> Ray >>> Rayilyn Brown >>> Past Director AZNPF >>> Arizona Chapter National Parkinson Foundation >>> >>> ---------------------------------------------------------------------- >>> To sign-off Parkinsn send a message to: mailto: >>> [log in to unmask] >>> In the body of the message put: signoff parkinsn >>> >> >> ---------------------------------------------------------------------- >> To sign-off Parkinsn send a message to: mailto: >> [log in to unmask] >> In the body of the message put: signoff parkinsn >> > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn